Acute mountain sickness is an illness that can affect mountain climbers, hikers, skiers, or travelers at high altitudes, usually above 8000
The drug acetazolamide (Diamox) can be used to help prevent altitude sickness. What is it? Altitude sickness is a common problem for mountain climbers and
Drugs used to treat Mountain Sickness / Altitude Sickness ; Generic name: dexamethasone systemic; Drug class: glucocorticoids; For consumers:
You might need medication to help combat Altitude sickness, also known as acute mountain sickness (AMS), can occur when ascending to high altitudes too quickly, such as when climbing mountains like Kilimanjaro, Mount Kenya, or the Rwenzori Mountains.
Diamox for Mountain Sickness / Altitude Sickness User Reviews. Diamox has an average rating of 8.0 out of 10 from a total of 10 reviews for the treatment of Mountain Sickness / Altitude Sickness. 80% of reviewers reported a positive experience, while 20% reported a negative experience.
Acetazolamide for Mountain Sickness / Altitude Sickness User Reviews. Acetazolamide has an average rating of 7.7 out of 10 from a total of 15 reviews for the treatment of Mountain Sickness / Altitude Sickness. 73% of reviewers reported a positive experience, while 20% reported a negative experience.
Acute mountain sickness is an illness that can affect mountain climbers, hikers, skiers, or travelers at high altitudes, usually above 8000
Mountain climbers often use a mixture of pure oxygen and air to relieve altitude sickness while climbing high mountains. In addition, the
Compare risks and benefits of common medications used for Mountain Sickness / Altitude Sickness. Find the most popular drugs, view ratings and user reviews.
Comments
Story is absolutely of the 'first water' (diamond industry speak) - Liked the slow build up as to what happened to his leg, Morgan and Wendy - Mountaineering wise, you seem to have more than a casual knowledge of the subject. I sadly also have more than a nodding acquaintance with mountain sickness. You a climber? (me too) . . . .